Tamoxifen exerts its effects on estrogen-receptor positive cells by binding to ERα.ERα expression is both necessary and sufficient to predict the responsiveness toanti-estrogen in a high proportion of breast tumors, and low expression level isgenerally associated with a poor prognosis [33–35,46,47]. This evidence concerns the gene ESR1 and breast neoplasm.